Adaptimmune Therapeutics plc - American Depositary Shares (ADAP)
0.0818
+0.0152 (22.82%)
NASDAQ · Last Trade: Sep 16th, 7:06 PM EDT
Detailed Quote
Previous Close
0.0666
Open
0.0926
Bid
0.0820
Ask
0.0821
Day's Range
0.0737 - 0.1019
52 Week Range
0.0403 - 1.120
Volume
476,331,493
Market Cap
125.62M
PE Ratio (TTM)
-0.7436
EPS (TTM)
-0.1
Dividend & Yield
N/A (N/A)
1 Month Average Volume
64,038,930
Chart
About Adaptimmune Therapeutics plc - American Depositary Shares (ADAP)
Adaptimmune is a biotechnology company focused on developing T-cell therapy to treat cancer. The company specializes in harnessing the power of the immune system, particularly using engineered T-cell receptors (TCRs), to target and eliminate cancer cells more effectively. Adaptimmune’s innovative approach aims to improve patient outcomes in various cancers by personalizing therapies to the individual’s unique tumor characteristics. Through ongoing research and clinical trials, the company strives to bring transformative treatment options to patients suffering from life-threatening malignancies. Read More
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.
As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
